Revanta Pharmaceuticals LLP

Revanta Pharmaceuticals LLP - chemicals in Kanpur, Uttar Pradesh, India. Directors, charges & compliance details.
LLPIN AAS-7624 Incorporated 03 July 2020 ROC Kanpur HQ Kanpur, Uttar Pradesh, India
Active Limited Liability Partnership chemicals
Data last updated
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
6 yrs
Est. 2020
Designated partners
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Kanpur
ROC office
Incorporated
03 Jul 2020
Date of incorporation
Entity type
LLP
As registered with MCA

About Revanta Pharmaceuticals LLP

Data last updated:

Revanta Pharmaceuticals LLP is a limited liability partnership (LLP) based in Kanpur, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 03 July 2020 and has been in existence for over 6 years.

The LLP is registered with the Registrar of Companies (ROC), Kanpur, under LLPIN AAS-7624.

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Joycee Vijay Rastogi and Varsha Rastogi.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 117/132 A P Block Hitkari Nagar Kakadeo, Kanpur, Uttar Pradesh, India – 208025.

Company Details of Revanta Pharmaceuticals LLP
LLPIN AAS-7624
Incorporation Date 03 July 2020
Total Obligation of Contribution ₹1 Lakh
ROC Kanpur
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Key People
Joycee Vijay Rastogi Designated Partner Varsha Rastogi Designated Partner
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    117/132 A P Block Hitkari Nagar Kakadeo, Kanpur, Uttar Pradesh, India – 208025
  • Industry
    Chemicals, Manufacturing, Chemicals And Chemical Products
Comprehensive company report
Revanta Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Revanta Pharmaceuticals LLP report

Financials, compliance, directors, charges, ownership and filings for Revanta Pharmaceuticals LLP in one report.

Financials from FY 2021 Directors & ownership Charges & compliance

Financials of Revanta Pharmaceuticals LLP FY 2025 filings available

Financial Statement Summary of Revanta Pharmaceuticals LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income and Expenditure
Turnover••••••••••••••••••••
Other Income••••••••••••••••••••
Total Income••••••••••••••••••••
Purchases and Direct Costs••••••••••••••••••••
Personnel Expenses••••••••••••••••••••
Administrative Expenses••••••••••••••••••••
Interest••••••••••••••••••••
Depreciation••••••••••••••••••••
Total Expenses••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax••••••••••••••••••••
Profit After Tax••••••••••••••••••••
Profit Transferred to Partners••••••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Secured Loans••••••••••••••••••••
Unsecured Loans••••••••••••••••••••
Trade Payables••••••••••••••••••••
Other Liabilities and Provisions••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Loans and Advances••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Revanta Pharmaceuticals LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
Net Profit Margin••••••••••••••••••••
Return on Partners' Funds••••••••••••••••••••
Return on Assets••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Debt to Partners' Funds••••••••••••••••••••
Interest Coverage••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Turnover Growth••••••••••••••••••••
Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Revanta Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2021

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Revanta Pharmaceuticals LLP

Revanta Pharmaceuticals has 2 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Joycee Vijay RastogiDesignated Partner03 Jul 20206 Years 3 MonthsCurrent
Varsha RastogiDesignated Partner16 Feb 20233 Years 8 MonthsCurrent
View all designated partners

Charges & Borrowings of Revanta Pharmaceuticals LLP

Revanta Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Revanta Pharmaceuticals LLP

Employment history and EPFO contributions of people linked to Revanta Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Revanta Pharmaceuticals LLP

Revanta Pharmaceuticals LLP has 3 designated partner changes on record since 2020: 2 appointments and 1 cessation. The latest: Varsha Rastogi ceased to be Designated Partner on 30 May 2023.

AGM
Revanta Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Revanta Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Varsha Rastogi ceased to be Designated Partner.
Appointed
Varsha Rastogi was appointed as Designated Partner.
Appointed
Joycee Vijay Rastogi was appointed as Designated Partner.
Incorporation
03 Jul 2020
Revanta Pharmaceuticals Llp was registered on 03 Jul 2020 with Roc Kanpur & aged 6 years 3 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Revanta Pharmaceuticals LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Revanta Pharmaceuticals LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Revanta Pharmaceuticals LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Revanta Pharmaceuticals LLP

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Revanta Pharmaceuticals LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Revanta Pharmaceuticals LLP

Revanta Pharmaceuticals is an active limited liability partnership based in Kanpur, Uttar Pradesh, India. The LLP works in manufacturing, within the chemicals industry. It was incorporated on 03 July 2020 (6+ years old) and is registered under LLPIN AAS-7624.

Revanta Pharmaceuticals has 2 current designated partners:

The LLPIN (Limited Liability Partnership Identification Number) of Revanta Pharmaceuticals is AAS-7624. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Revanta Pharmaceuticals was incorporated on 03 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.

Varsha Rastogi ceased to be Designated Partner on 30 May 2023. Varsha Rastogi was appointed as Designated Partner on 16 Feb 2023. Joycee Vijay Rastogi was appointed as Designated Partner on 03 Jul 2020.

The registered office of Revanta Pharmaceuticals is at 117132 A P Block Hitkari Nagar Kakadeo, Kanpur, Uttar Pradesh, India – 208025.

The total obligation of contribution is ₹1 Lakh.

Revanta Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

Revanta Pharmaceuticals can be reached at its registered office: 117132 A P Block Hitkari Nagar Kakadeo, Kanpur, Uttar Pradesh, India – 208025.

Revanta Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available